KPF
IMDZ

K2 Principal Fund’s Immune Design Corp. IMDZ Stock Holding History

K2 Principal Fund’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-158,255
Closed -$926K – 423
2019
Q1 		$926K Buy
+158,255
New +$539K 0.12% 195

K2 Principal Fund's IMDZ Position: Q2 2019 in Review

K2 Principal Fund sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 158,255 shares — an estimated $926K sold.

K2 Principal Fund first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $926K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • K2 Principal Fund reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
  • K2 Principal Fund sold 158,255 Immune Design Corp. shares in Q2 2019, an estimated $926K.
  • K2 Principal Fund first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
  • K2 Principal Fund's Immune Design Corp. position peaked at $926K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on K2 Principal Fund's 13F filing for Q2 2019, filed 14 Aug 2019.